Table 8.
Group | n | Relapsed | Healthy | P value |
---|---|---|---|---|
XEBT group | 195 | 25 (12.82%) | 170 (87.18%) | 0.4314 |
Placebo group | 4 | 1 (25.00%) | 3 (75.00%) |
Group | n | Relapsed | Healthy | P value |
---|---|---|---|---|
XEBT group | 195 | 25 (12.82%) | 170 (87.18%) | 0.4314 |
Placebo group | 4 | 1 (25.00%) | 3 (75.00%) |